Skip to main content
Glama

Ens

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description discloses substantial behavior beyond the readOnly/idempotent annotations: graceful degradation when GLEIF/OpenFIGI are unavailable, internal cascading through lookup endpoints, explicit handling of unresolved identifiers, ISIN-to-LEI mapping, and resolution of non-ticker instruments. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and uses examples, labeled types, and clear behavioral notes, but the company type section is a long, heavily nested parenthetical that is harder to parse than the rest. It is still front-loaded and largely free of waste, so it earns a 4.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, and the description compensates fully: it lists the returned identifiers (CIK, ticker, company_name, LEI, FIGI, RxCUI, ingredient, brand, citation), states unresolved-identifier behavior, covers ownership/subsidiary queries, and describes edge cases like non-US issuers and unavailable enrichment sources. Nothing essential is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Even though schema coverage is 100%, the description adds critical operational meaning: for bonds pass the issuer name exactly as printed and never the full noun phrase, accept ticker/CIK/ISIN/name for company, and accept brand or generic for drug. This materially reduces misinvoation risk.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb and resource: resolve a user-spoken NAME to the canonical/official identifiers other tools require. It opens with concrete natural-language examples and explicitly says 'Use FIRST whenever you have a name but need an ID,' which clearly distinguishes it from siblings like resolve_ens or entity_profile.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives a clear condition: use when you have a name but need an identifier, and it details per-type input handling (company, drug) and special cases like non-equity instruments. It does not explicitly name alternative tools or state when not to use it, so it stops short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Ens toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.3/5.0
Disambiguation5/5

Each tool has a clearly defined, distinct purpose. Even closely related tools like ask_pipeworx and ask_pipeworx_grounded are differentiated by use case (casual vs. high-stakes), and the prediction market tools each cover a specific function (research, edge detection, arbitrage, fill risk, tracking, cross-venue spreads). Detailed descriptions eliminate ambiguity.

Naming Consistency4/5

Tool names predominantly follow a verb_noun pattern (e.g., ask_pipeworx, compare_entities, resolve_entity), but a few use noun_noun or adjective_noun forms (e.g., entity_profile, recent_alerts). The naming is generally predictable and readable, with minor deviations from a strict pattern.

Tool Count3/5

The server offers 32 tools, which is above the typical 3-15 range for a well-scoped server. However, the vast domain (financials, prediction markets, news, memory, subscriptions, etc.) justifies the count. It is on the heavy side but still manageable with clear organization.

Completeness5/5

The tool surface is remarkably complete for the apparent domain: exploration (discover_tools, suggest_questions), identifier resolution (resolve_entity), data retrieval (ask_pipeworx, deep_research, entity_profile, compare_entities, recent_changes, validate_claim), prediction market analysis (full suite), memory (remember/recall/forget), subscriptions (subscribe/unsubscribe/list/recent_alerts), and extras (ENS, dependency scan, AI visibility). No obvious gaps exist.

Resources